Debt-to-equity of Twist Bioscience Corp from 30 Jun 2019 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Twist Bioscience Corp quarterly Debt-to-equity in % history and change rate from 30 Jun 2019 to 31 Dec 2025.
  • Twist Bioscience Corp Debt-to-equity for the quarter ending 31 Dec 2025 was 36%, a 23% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Twist Bioscience Corp Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q4 2025 36% +6.9% +23% 31 Dec 2025
Q3 2025 35% +7.6% +28% 30 Sep 2025
Q2 2025 33% +7.5% +29% 30 Jun 2025
Q1 2025 32% +7.8% +32% 31 Mar 2025
Q4 2024 29% +6.2% +27% 31 Dec 2024
Q3 2024 27% +4.5% +20% 30 Sep 2024
Q2 2024 26% +3.8% +17% 30 Jun 2024
Q1 2024 24% +3.3% +15% 31 Mar 2024
Q4 2023 23% +3% +15% 31 Dec 2023
Q3 2023 23% +1.7% +8.3% 30 Sep 2023
Q2 2023 22% +1.3% +6.4% 30 Jun 2023
Q1 2023 21% +0.38% +1.9% 31 Mar 2023
Q4 2022 20% +1.4% +7.4% 31 Dec 2022
Q3 2022 21% +6.2% +42% 30 Sep 2022
Q2 2022 21% +7% +51% 30 Jun 2022
Q1 2022 21% +8% +62% 31 Mar 2022
Q4 2021 19% +3.6% +23% 31 Dec 2021
Q3 2021 15% -11% -43% 30 Sep 2021
Q2 2021 14% -14% -51% 30 Jun 2021
Q1 2021 13% -18% -59% 31 Mar 2021
Q4 2020 15% -18% -53% 31 Dec 2020
Q3 2020 26% +5.8% +29% 30 Sep 2020
Q2 2020 28% -19% -41% 30 Jun 2020
Q1 2020 31% 31 Mar 2020
Q4 2019 33% 31 Dec 2019
Q3 2019 20% 30 Sep 2019
Q2 2019 47% 30 Jun 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.